Breathe Well Live Well-SM
Condition: Inadequately Controlled Asthma
Intervention: Biological: Tralokinumab open-label
Sponsor: AstraZeneca
Not yet recruiting – verified September 2016
View full post on ClinicalTrials.gov: asthma | Studies received in the last 14 days
Condition: Asthma
Intervention: Behavioral: CampAir
Sponsors: 3-C Institute for Social Development; Columbia University; New York University
Recruiting – verified June 2016
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Bel Marra Health |
Severe asthma linked to insomnia, sleep duration, and sleep hygiene in adolescents
Bel Marra Health severe-asthma-linked-to-insomnia-sleep-duration-and- Severe asthma is linked to insomnia, sleep duration, and sleep hygiene in adolescents. The findings were published in The Journal of Allergy and Clinical Immunology: In Practice. The researchers … |
View full post on asthma – Google News
|
SPIRIVA® RESPIMAT® Now Available in the U.S. for Maintenance Treatment of Asthma in Adults and Adolescents
Business Wire (press release) INGELHEIM, Germany–(BUSINESS WIRE)–Boehringer Ingelheim today announced that SPIRIVA® RESPIMAT® is now available for the treatment of asthma by prescription in U.S. pharmacies. The U.S. Food and Drug Administration (FDA) approved a … |
View full post on asthma – Google News
|
SPIRIVA ® RESPIMAT ® Now Available in the US for Maintenance Treatment of Asthma in Adults and Adolescents
Business Wire (press release) INGELHEIM, Germany–(BUSINESS WIRE)–Boehringer Ingelheim today announced that SPIRIVA® RESPIMAT® is now available for the treatment of asthma by prescription in U.S. pharmacies. The U.S. Food and Drug Administration (FDA) approved a … SPIRIVA RESPIMAT Now Available in the US for Maintenance Treatment of Asthma in Adults and Adolescents |
View full post on asthma – Google News